Komodo Health, a San Francisco, and NYC-based provider of software to answer healthcare’s most complicated questions, raised $50m in series C funding.
The round was led by Andreessen Horowitz, with participation from Oak HC/FT also and previous investors IA Ventures and Felicis Ventures.
The company intends to use the funds to create new software for life sciences, payers, advocacy groups and provider organizations while accelerating the expansion of its Healthcare Map, a real-time view into healthcare journeys in the US.
Led by Arif Nathoo, MD, CEO and co-founder, Komodo Health applies artificial intelligence and other advanced analytical techniques to provide organizations with solutions to address healthcare challenges ranging from cost and quality to misdiagnosis and healthcare disparities.
The Healthcare Map tracks the unique patient journeys of over 320 million patients. As a result, the company empowers a multitude of healthcare stakeholders — life science companies, healthcare payers and providers, patient advocacy groups, and others — to create a more cost-effective, value-driven healthcare system. For example, underpinned by the map, Komodo’s software-as-a-service (SaaS) technology can pinpoint geographic disparities in care delivery, and then drive intervention at the healthcare provider level to improve quality and outcomes for patients.
Seventy healthcare organizations are currently licensing Komodo Health’s platform and solutions, spanning life sciences, government agencies, patient advocacy, payers, labs, technology companies, and research groups. The company’s client roster includes 19 of the top 20 pharmaceutical companies.